Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

GSK presents preclinical data on novel S1P1 agonist, PPI-4955, at recent ACS meeting

Aug. 26, 2009

T-type calcium channel antagonist TTA-A8 a clinical candidate for sleep disorders

Aug. 26, 2009

Preclinical characteristics of antidiabetic candidate canagliflozin described

Aug. 26, 2009

Abbott presents PAMs that target the alpha7 nicotinic acetylcholine receptor

Aug. 25, 2009

Takeda describes preclinical profile of GnRH antagonist TAK-385

Aug. 25, 2009

MF-482 developed as a second-generation EP4 antagonist for treating inflammatory pain

Aug. 25, 2009

Cephalon details discovery and testing of c-Met inhibitors for cancer

Aug. 24, 2009

Wyeth presents novel benzofuran analogues designed to inhibit NE reuptake

Aug. 24, 2009

Pure androgen receptor antagonist CH-4933468 developed at Chugai

Aug. 24, 2009

Novel IKK2-inhibiting compounds tested for antiarthritic potential at GlaxoSmithKline

Aug. 24, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...